Pulmonary embolism rate in patients infected with SARS-CoV-2.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. COVID-19 on Chest CT: Translating Known Microscopic Findings to Imaging Observations.Life (Basel, Switzerland) · 2022
   Article
2. Impact of the COVID-19 Pandemic on Trends in Cardiothoracic Imaging.Radiology research and practice · 2022
   Article
3. Pulmonary infarcts in COVID-19.Clinical imaging · 2021
   Article
4. An Exploratory Review of Potential Adjunct Therapies for the Treatment of Coronavirus Infections.Journal of chiropractic medicine · 2021
   Review
5. Pathophysiology and Imaging Findings of COVID-19 Infection: An Organ-system Based Review.Academic radiology · 2021
   Review
6. Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.Thrombosis update · 2021
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.